Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07154602

Esthetic Outcome of 3D Printed Hybrid Ceramics as Final Restorations for Single Screw Retained Implant.

clinical trial

The goal of this clinical trial is to record the esthetic outcome of the 3d printed hybrid resin crowns. It will also test which method of fabrication is advantageous than the other one. The main questions it aims to answer are:

Does any of the fabrication methods differ in its esthetic outcome?

Researcher will compare 3d printing fabrication to conventional fabrication method which is the milling technique to see if 3d printing of hybrid resin serves patients a better crown's esthetic outcome.

Participants will:

Receive a crown after implants are osseointegrated Visit the clinic once every 3 months for checkups and tests Keep records of level of patient's satisfaction.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: between 18 and 70 years old at the time of screening.
  • Patients with implants placed and in need for crown restoration
  • Medically free with no systemic diseases.
  • Good oral hygiene with no active periodontal disease.
  • Patient's having adequate interocclusal and mesiodistal restorative space for the fabrication of a single implant-supported crown.
  • Patients willing and able to provide written informed consent for participation in the study, understanding its risks, benefits, and alternative treatments.

Exclusion criteria

  • Uncontrolled systemic diseases (e.g., uncontrolled diabetes, severe cardiovascular disease, active autoimmune disorders, uncontrolled thyroid dysfunction).
  • Patients with composite restoration on the labial/buccal surface implant's neighbouring.
  • Immunocompromised patients or those undergoing immunosuppressive therapy.
  • Patients undergoing radiation therapy to the head and neck region, or chemotherapy.
  • Patients currently on or with a history of medications known to significantly affect bone metabolism (e.g., long-term bisphosphonates, corticosteroids).
  • Pregnancy or lactation.
  • Known allergies to titanium, resin components, or any other materials used in the study (e.g., composite, zirconia).

Treatment and study plan

3D printed hybrid resin ceramic crowns

Other

3D printed hybrid resin ceramic crowns in anterior and premolar maxillary teeth

milled hybrid resin ceramic crown

Other

milled hybrid resin ceramic crown on implants in anterior and premolar maxillary teeth

Primary outcomes

  1. Aesthetic appearance

    Time frame: 6 months

    using visual analogue scale, patient rating from 0 to 10 where 10 is satisfied the most while 0 is least satisfied

Secondary outcomes

  1. Prosthetic complications

    Time frame: 6 months

    Abutment fracture or crown fracture

Study contacts

Contact information is provided by the study sponsor or research team.

Nourhan Gamal Dr.Nourhan Gamal AbdEl-Aziz, Master holder

CONTACT

[email protected]

01064249441

Sponsors and collaborators

Lead sponsor

International Dental Contiuing Education

Network

Registry information

Official study title

Esthetic Outcome of 3D Printed Hybrid Ceramics as Final Restorations for Single Screw Retained Implant. A Clinical Randomized Clinical Trial

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 4, 2025
Registry last updated
Sep 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.